S&P 500   4,297.81 (+0.09%)
DOW   33,819.11 (-0.04%)
QQQ   353.23 (+0.02%)
AAPL   181.04 (+0.26%)
MSFT   325.73 (+0.14%)
META   264.00 (-0.22%)
GOOGL   122.00 (-0.11%)
AMZN   123.40 (-0.68%)
TSLA   242.30 (+3.17%)
NVDA   386.02 (+0.24%)
NIO   7.78 (-0.13%)
BABA   85.68 (-0.53%)
AMD   123.84 (+2.30%)
T   16.01 (-0.37%)
F   13.81 (+1.69%)
MU   64.79 (-0.81%)
CGC   0.67 (-2.87%)
GE   105.34 (-0.69%)
DIS   91.71 (-0.89%)
AMC   4.72 (+0.85%)
PFE   39.02 (-0.18%)
PYPL   63.16 (-1.68%)
NFLX   422.03 (+3.09%)
S&P 500   4,297.81 (+0.09%)
DOW   33,819.11 (-0.04%)
QQQ   353.23 (+0.02%)
AAPL   181.04 (+0.26%)
MSFT   325.73 (+0.14%)
META   264.00 (-0.22%)
GOOGL   122.00 (-0.11%)
AMZN   123.40 (-0.68%)
TSLA   242.30 (+3.17%)
NVDA   386.02 (+0.24%)
NIO   7.78 (-0.13%)
BABA   85.68 (-0.53%)
AMD   123.84 (+2.30%)
T   16.01 (-0.37%)
F   13.81 (+1.69%)
MU   64.79 (-0.81%)
CGC   0.67 (-2.87%)
GE   105.34 (-0.69%)
DIS   91.71 (-0.89%)
AMC   4.72 (+0.85%)
PFE   39.02 (-0.18%)
PYPL   63.16 (-1.68%)
NFLX   422.03 (+3.09%)
S&P 500   4,297.81 (+0.09%)
DOW   33,819.11 (-0.04%)
QQQ   353.23 (+0.02%)
AAPL   181.04 (+0.26%)
MSFT   325.73 (+0.14%)
META   264.00 (-0.22%)
GOOGL   122.00 (-0.11%)
AMZN   123.40 (-0.68%)
TSLA   242.30 (+3.17%)
NVDA   386.02 (+0.24%)
NIO   7.78 (-0.13%)
BABA   85.68 (-0.53%)
AMD   123.84 (+2.30%)
T   16.01 (-0.37%)
F   13.81 (+1.69%)
MU   64.79 (-0.81%)
CGC   0.67 (-2.87%)
GE   105.34 (-0.69%)
DIS   91.71 (-0.89%)
AMC   4.72 (+0.85%)
PFE   39.02 (-0.18%)
PYPL   63.16 (-1.68%)
NFLX   422.03 (+3.09%)
S&P 500   4,297.81 (+0.09%)
DOW   33,819.11 (-0.04%)
QQQ   353.23 (+0.02%)
AAPL   181.04 (+0.26%)
MSFT   325.73 (+0.14%)
META   264.00 (-0.22%)
GOOGL   122.00 (-0.11%)
AMZN   123.40 (-0.68%)
TSLA   242.30 (+3.17%)
NVDA   386.02 (+0.24%)
NIO   7.78 (-0.13%)
BABA   85.68 (-0.53%)
AMD   123.84 (+2.30%)
T   16.01 (-0.37%)
F   13.81 (+1.69%)
MU   64.79 (-0.81%)
CGC   0.67 (-2.87%)
GE   105.34 (-0.69%)
DIS   91.71 (-0.89%)
AMC   4.72 (+0.85%)
PFE   39.02 (-0.18%)
PYPL   63.16 (-1.68%)
NFLX   422.03 (+3.09%)
NASDAQ:NYMX

Nymox Pharmaceutical (NYMX) Earnings Date, Estimates & Call Transcripts

$0.39
-0.01 (-1.83%)
(As of 12:25 PM ET)
Compare
Today's Range
$0.39
▼
$0.40
50-Day Range
$0.32
▼
$0.49
52-Week Range
$0.19
▼
$0.74
Volume
18,872 shs
Average Volume
53,332 shs
Market Capitalization
$35.45 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

NYMX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

NYMX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

NYMX Earnings Date and Information

Nymox Pharmaceutical has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 21st, 2023 based off prior year's report dates.

Nymox Pharmaceutical Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/21/2023
(Estimated)		        
11/14/2022Q3 2022($0.02)($0.02)($0.02)
8/15/2022Q2 2022$0.01+$0.01$0.01
5/13/2022Q1 2022($0.06)($0.06)($0.06)
3/30/2022Q4 2021($0.03)($0.03)($0.03)
11/12/2021Q3 2021($0.04)($0.04)($0.04)
8/13/2021Q2 2021($0.05)($0.05)($0.05)
5/14/2021Q1 2021($0.03)($0.03)($0.03)
3/29/2021Q4 2020($0.03)($0.03)($0.03)
11/13/2020Q3 2020($0.06)($0.06)($0.06)
8/17/2020Q2 2020($0.04)($0.04)($0.04)
5/14/2020Q1 2020($0.04)($0.04)($0.04)$0.01 million
3/30/2020Q4 2019($0.04)($0.04)($0.04)$0.03 million
11/13/2019Q3 2019($0.04)($0.04)($0.04)$0.04 million
8/14/2019Q2 2019($0.08)($0.08)($0.08)$0.02 million
5/15/2019Q1 2019($0.04)($0.04)($0.04)$0.03 million
3/29/2019Q4 2018($0.05)($0.05)($0.05)$0.02 million
11/13/2018Q3 2018($0.05)($0.05)($0.05)$0.04 million
8/13/2018Q2 2018($0.04)($0.04)($0.04)$0.09 million
5/15/2018Q1 2018($0.05)($0.05)($0.05)$0.15 million
3/30/2018Q4 2017($0.06)($0.06)($0.06)$0.11 million
11/6/2017Q3 2017($0.09)($0.09)($0.09)$0.03 million
8/7/2017Q2 2017($0.05)($0.05)($0.05)$0.01 million
5/15/2017Q1 2017($0.06)($0.06)($0.06)$0.08 million
3/31/2017Q4 2016($0.06)($0.06)($0.06)$0.04 million
11/15/2016Q3 2016($0.07)($0.07)($0.07)$0.05 million
8/22/2016Q2 2016($0.08)($0.08)($0.08)$0.15 million
5/16/2016Q1 2016($0.07)($0.07)($0.07)$0.04 million
3/30/2016Q4 2015($0.10)($0.10)($0.10)$0.08 million
12/31/2015Q3 2015($0.26)($0.26)($0.26)$0.05 million
8/24/2015Q2 2015($0.63)($0.63)($0.63)$0.06 million
5/15/2015Q1 2015$0.04+$0.04$0.04$0.08 million
3/31/2015Q4 2014($0.01)($0.01)($0.01)$0.08 million
11/14/2014Q314($0.02)($0.02)($0.02)$0.08 million  
8/11/2014Q2 2014($0.02)($0.02)($0.02)$0.10 million
5/15/2014Q1 2014($0.07)($0.07)($0.07)$0.08 million
3/14/2014Q4 2013($0.03)($0.03)($0.03)$0.94 million
11/14/2013Q3 2013($0.03)($0.03)($0.03)$0.74 million
8/14/2013Q2 2013($0.04)($0.04)($0.04)$0.19 million
5/15/2013Q1 2013($0.03)($0.03)($0.03)$0.78 million$0.18 million  
3/15/2013Q4 2012($0.05)($0.08)($0.03)($0.08)
11/14/2012Q312($0.06)($0.04)+$0.02
8/14/2012Q2 2012($0.06)($0.05)+$0.01($0.05)
5/15/2012Q1 2012($0.06)($0.06)($0.06)
3/15/2012Q4 2011($0.06)($0.06)($0.06)
11/14/2011Q3 2011($0.05)($0.05)($0.05)
8/12/2011Q2 2011($0.04)($0.06)($0.02)($0.06)
5/13/2011Q1 2011($0.05)($0.14)($0.09)($0.14)
3/15/2011Q4 2010($0.05)($0.07)($0.02)($0.07)
11/12/2010Q3 2010($0.05)($0.05)($0.05)
8/13/2010Q2 2010($0.05)($0.05)($0.05)
5/14/2010Q1 2010($0.04)($0.04)($0.04)
3/11/2010Q4 2009($0.05)($0.05)($0.05)
11/13/2009Q3 2009($0.04)($0.04)($0.04)
8/14/2009Q2 2009($0.04)($0.04)($0.04)
5/15/2009Q1 2009($0.03)($0.03)($0.03)
11/14/2008Q3 2008($0.05)($0.05)($0.05)
8/13/2008Q2 2008($0.04)($0.04)($0.04)
5/14/2008Q1 2008($0.04)($0.04)($0.04)
3/14/2008Q4 2007($0.04)($0.04)($0.04)












Nymox Pharmaceutical Earnings - Frequently Asked Questions

When is Nymox Pharmaceutical's earnings date?

Nymox Pharmaceutical has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 21st, 2023 based off last year's report dates. Learn more on NYMX's earnings history.

How much profit does Nymox Pharmaceutical generate each year?

Nymox Pharmaceutical (NASDAQ:NYMX) has a recorded net income of -$6.58 million. NYMX has generated -$0.04 earnings per share over the last four quarters.

More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:NYMX) was last updated on 6/9/2023 by MarketBeat.com Staff

My Account -